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Abstract. The agents of human febrile illness can vary by region and country suggesting that diagnosis, treatment,
and control programs need to be based on a methodical evaluation of area-specific etiologies. From December 2006 to
December2009,9,997individualspresentingwithacutefebrileillnessatninehealthcareclinicsinsouth-centralCambodia
were enrolled in a study to elucidate the etiologies. Upon enrollment, respiratory specimens, whole blood, and serum
were collected. Testing was performed for viral, bacterial, and parasitic pathogens. Etiologies were identified in 38.0% of
patients. Influenza was the most frequent pathogen, followed by dengue, malaria, and bacterial pathogens isolated from
blood culture. In addition, 3.5% of enrolled patients were infected with more than one pathogen. Our data provide the
first systematic assessment of the etiologies of acute febrile illness in south-central Cambodia. Data from syndromic-
basedsurveillance studies canhelp guide public healthresponses indevelopingnations.
INTRODUCTION
Limited resources and the great diversity of acute febrile
illness (AFI) etiologies in tropical regions challenge diagno-
sis, treatment, and public health responses to endemic and
epidemic diseases. Further confounding this is the fact that a
majority of the patients present with non-descript symptoms
(e.g., low-grade fever, general malaise, headache, and muscle
ache) and usually no focal point of infection. Health care pro-
viders lacking proper diagnostic tools are usually unable to
determine specific etiologies, often diagnosing patients pre-
sumptively based on clinical features and assumptions regard-
ing circulating pathogens.
Syndromic-based disease surveillance provides a useful
methodology to systematically identify and document causes of
acute fever. This approach has been used by TropNetEuropa ¨
1,2
to diagnose fevers of unknown origin in Turkey,
3 China,
4 and
India and a project designed by the U.S. Centers for Disease
Control and Prevention (CDC, Atlanta, GA) for the same
purposealongtheUnitedStates-Mexicoborder.
In Southeast (SE) Asia, a prospective study of Thai patients
presenting with acute undifferentiated febrile illness deter-
mined the etiologies of over 40% of cases, with the most prev-
alent being influenza, dengue, and rickettsial infections.
5 In
Latin America, surveillance identified the etiology of acute
undifferentiated febrile illness in Ecuador in 40% of enrolled
patients, identifying a number of pathogens that have not pre-
viouslybeenisolated in the country.
6
Emergingandre-emergingdiseasesareaconcerninSEAsia
during a dynamic time of population growth, urbanization,
and global migration. Infections from dengue virus, malaria
parasites, influenza viruses, hepatitis viruses, rickettsiae, and
Leptospira have previously been shown to impact popula-
tions across SE Asia. However, among the SE Asian nations,
limited data exists on the etiologies of AFI in the Kingdom
of Cambodia. Earlier studies reported illnesses among
Cambodian refugee populations that had either immigrated
to the United States or occupied refugee camps in Thailand.
7,8
These works documented infections by agents such as malaria,
hepatitis, cryptosporidium, and tuberculosis that presented in
an often stressed and undernourished patient cohort. More
recent studies conducted in Cambodia used both prospective
and/or syndromic approaches. Infectious etiologies of enceph-
alitic syndromes among patients admitted to a provincial hos-
pital near Phnom Penh
9 were identified in 35 of 88 (40%)
human immunodeficiency virus (HIV)-seronegative patients;
11bacterial,1fungal,and23viralinfections(Japaneseenceph-
alitis virus [JEV] the principal causative agent of disease). A
hospital-based study among children in Phnom Penh was con-
ducted to diagnose hemorrhagic fever, encephalitis, or hepatitis
in children,
10 reporting that hepatitis A and JEV contributed
greatly to the burden of disease in this population. In 2006, we
initiated clinic-based surveillance to ascertain the etiologies of
AFI among patients seeking treatment at peri-urban and rural
health care clinics and hospital outpatient departments in
Cambodia. Herein, we describe the demographics, symptoms,
and identified etiologies of the patients seeking health care for
AFIfromDecember2006to December2009.
MATERIALS AND METHODS
Ethical considerations. Eligible subjects voluntarily enrolled
in accordance with an Institutional Review Board proto-
col approved by U.S. Naval Medical Research Unit Two
(NAMRU2) in compliance with all applicable Federal regu-
lations governing the protection of human subjects and
the National Ethics Committee of the Royal Kingdom of
Cambodia, Ministry of Health. Written consent was obtained
from patients 18 years of age and older. For patients younger
than 18 years of age, written consent was obtained from a
parent or legal guardian. Additionally, written assent was
obtained from patients between 8 and 17 years of age. For all
individuals, the informed consent was verbally explained and
questionssolicited.
Site selection and study enrollment. Clinic-based acute
fever surveillance was initiated in December 2006. Patients
were initially recruited from outpatient clinics of two referral
hospitals, but during the course of the study, additional clinics
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246were added: two in August 2007, one in October 2007, one
in December 2007, one in February 2007, one in March 2008,
and one in April 2008, for a total of nine. Five of the health
care sites were located in Operational District A (peri-urban);
four health care sites were located in Operational District B
(rural). All health care sites were located within 50 km of
Phnom Penh in south-central Cambodia (Figure 2).
Patients were asked to enroll if they meet the inclusion cri-
teria, which included: a measured tympanic membrane tem-
perature > 38.0 C when at the study site and, as reported by
the enrollee, a fever duration of at least 24 hours and < 10 days,
were 2 years of age or older, and after medical examination,
their illness was not able to be diagnosed during the patient’s
physical examination or medical history.
5Patientswereexcluded
if they declined to participate in the study or did not meet any
of the inclusion criteria. A physician or medical assistant in
each clinic obtained written informed consent, administered a
pretested enrollment questionnaire, and performed a medical
examination. Laboratory technicians collected blood and
throat and nasal swabs. All study participants were directed
to return 14 to 21 days for a follow-up appointment, in which a
convalescent blood specimen was collected (Figure 1). All
clinical specimens were transported to a central laboratory
where testing for several infectious agents was performed.
Definitions. Influenza-like illness was defined by fever
(>38.0 C),pluscoughorsorethroat.
11–13Diarrheawasdefined
as two or more loose liquid stools in any 24-hour period as all
enrolled patients had the symptom of fever. Probable dengue
was defined as only having a positive immunoglobulin M (IgM)
result and confirmed dengue was defined as having a positive
polymerase chain reaction (PCR) result. Recent travel was
defined as the individual leaving their respective home for at
least 5 consecutive days within 2 months preceding enrollment.
Operational district is a designation used by the Cambodian
government to denote a continuous geographic region under
thepurviewofasinglegovernmentoffice.
Specimen collection. For each enrollee, a blood specimen
was obtained by venipuncture and one throat and one nasal
swab were collected. For nasal swabs, a dry polyester swab
was inserted into the nostril, parallel to the palate, slowly
withdrawn, and placed in a vial containing 2–3 mL of virus
transport medium. For throat swabs, both tonsils and the
posterior pharynx were swabbed vigorously, and the swab
placed in 2–3 mL of virus transport medium. All inoculated
vials were kept at 4 C until transported to NAMRU2/NIPH’s
laboratory. All specimens were accessioned at the laboratory
between 24 and72 hourspost collection.
Malaria smears. At the time of enrollment a blood smear is
prepared and transported (daily) to the laboratory for staining
byGiemsa stainandinterpretation bymicroscopy.
Blood cultures. Asinglebloodculturewasobtainedfromall
enrolled patients in an aerobic BacT/Alert 3D (bioMerieux,
Hazelwood, MO) bottle. Daily, inoculated bottles were
transported to the NAMRU2 laboratory in Phnom Penh
and then incubated for up to 7 days in the BacT/Alert blood
culture system. A sample of blood from positive blood
cultures was inoculated onto chocolate, MacConkey’s, and
blood agar plates and incubated at 37 C, 5% CO2, for up to
48 hours. Bacterial identification was done using the API 20E
biochemical identification system (bioMerieux).
Serological assays. All commercial enzyme-linked immu-
nosorbent assay (ELISA) test assays were performed and
interpreted according to the manufacturer’s instruction as
Positive, Equivocal, and Negative. Dengue IgM serological
assays were performed on all acute serum samples from all
study participants using the Dengue IgM Capture ELISA Dx
Select (Focus Diagnostics, Cypress, CA). Hepatitis A IgM was
performed with the Hepalisa Anti-HAV IgM (PT INDEC
DIAGNOSTICS, Jakarta, Indonesia). Hepatitis B surface
antigen was detected using the Hepalisa HBsAg (PT INDEC
DIAGNOSTICS). An IgM serological response to hepatitis E
was detected using the HEV IgM ELISA 3.0 (MP Biomedicals,
Singapore). An acute immunological response was detected
to Leptospira using the Leptospira IgM ELISA (PANBIO,
Brisbane, Australia).
The IgG serology was performed for dengue, Hantavirus,
chikungunya, and Rickettsia on all convalescent serum sam-
ples. All commercial ELISA test assays were performed and
interpreted according to the manufacturer’s instruction as
Positive, Equivocal, and Negative. Convalescent specimens
that were found to be IgG positive were paired with the acute
serum and retested. A 4-fold increase in titer from acute to
convalescent sample, or a result change going from nega-
tive to positive, was considered indicative of seroconversions.
Detection of dengue IgG and hantavirus IgG were accom-
plished by using the Dengue IgG capture ELISA (PANBIO)
and Hantavirus IgG ELISA Dx Select (Focus Diagnostics),
respectively. Chikungunya virus-specific IgG was detected by
ELISA as previously published.
14 The IgG ELISA specific for
typhus group and scrub typhus rickettsiae and spotted fever
group ricketssiae were performed as previously described.
15,16
A 4-fold increase in titer from acute to convalescent sample,
or a result change going from negative to positive, was consid-
ered indicativeof seroconversions.
PCR amplification. Influenza. The RNA was extracted
from nasal and throat swabs using QIAamp viral RNA mini
FIGURE 1. Flow chart of patient enrollment, information collected,
andtesting algorithms.
FEBRILE SURVEILLANCE IN CAMBODIA 247kits (QIAGEN, Hilden, Germany) following manufacturer’s
instruction and stored at  80 C. Influenza virus genome was
detected using a standardized real-time reverse transcription
(rRT)-PCR assay developed by the U.S. CDC to detect
influenza A and B viruses as well as influenza A viruses of
H1, H3, and H5 subtypes. Real time assays were developed
at the CDC and assays and primer sequences are available
upon request under a Material Transfer Agreement. One-step
rRT-PCRwasperformedinafinalvolumeof25mLcontaining
5 mL of extracted RNA, 12.5 mL of buffer mix, and 0.5 mL
Superscript III/Platinum Taq-Enzyme mix, 20 U of RNAse-
out (Invitrogen, Carlsbad, CA), 0.8 mM for each primer, and
0.2 mM of probe. The Rotor-Gene 6000 real time thermocyler
(Corbett Life Science, Sydney, Australia) was used for all
PCR reactions. The thermocycling parameters for all targets
consisted of 50 C for 30 minutes, 95 C for 2 minutes, and
45 cycles with 95 C for 15 seconds, 55 C for 30 seconds
(U.S.CDC).InAugust2009,areal-timePCRassaydistributed
bytheU.S.CDCwasintroduced forthedetectionofpandemic
H1N1 influenza virus. The Applied Biosystems 7500 real time
thermocycler (Applied Biosystems, Foster City, CA) was used
forall pH1N1PCR reactions.
Nested conventional PCR for dengue. Denguevirusgenome
and serotype detection was based on previously published
procedureswith modifications tothe Dengue-1 primer.
17,18
Nested reverse real-time PCR for chikungunya virus. The
RNA was extracted from serum using QIAamp viral RNA
mini kits (QIAGEN) following manufacturer’s instruction
and stored at  80 C. Chikungunya virus genome was detected
usinganestedRT-PCRassay,whichcomprisestwoassaysteps;
RT-PCR and nested PCR (nPCR). The RT reactions were
performedin25mLcontaining5mLofAccessAMV-Tflbuffer
(Promega, Madison WI), 1.5 mL of 25 mM MgSO4,1mLo f
10 mM deoxynucleoside triphosphate (dNTP; final concen-
tration, 200 mM), 20 pico moles each of all outer primers sets,
0.5 mL of AMV-reverse transcriptase, and 0.5 mL of 5 U Tfl
polymerase (Promega), and 5 mL of RNA template. The PCR
thermalcyclingwasperformed asfollows:48 Cfor45minutes,
94 C for 2 minutes, and 40 cycles with 94 C for 1 minute, 60 C
for1minute,68 Cfor1minute,andthen68 Cfor7minutes.All
thermal cycling was performed with Applied Biosystems type
9700 machine. Inner primer pairs are then used in separate
nPCR reactions using GeneAmp PCR Core reagent (Applied
Biosystems). The nPCR reactions were performed in 25 mL
containing 2.5 mLo fA B IP C Rb u f f e r ,1 . 5mLo f2 5m MM g C l 2,
2.0 mL of 10 mM dNTP (final concentration 200 mM), 1.0 mLo f
10 mM forward primer, and 1.0 mL of reverse primer, 0.25 mL
of 5 units of AmpliTaq DNA Polymerase, and 5 mL of diluted
(1:50) RT-PCR product. The cycle conditions of the nPCR
reaction were as follows; 94 C for 2 minutes, and 40 cycles with
94 C for 30 seconds, 60 C for 30 seconds, 72 C for 30 seconds,
and then 72 C for 10 minutes. Outer and inner primer pairs
are designed to amplify three structural gene regions, Capsid
(C), Envelope-2 (E2), and an area overlapping the 6K and E1
genes (6K/E1).
14 The PCR products were visualized on 2%
agarose gels stained with ethidium bromide under UV light.
A positive result was indicated upon observation of a 200 base
pair PCR product, representing the capsid, and at least one of
the envelopetargets ispresent.
Quantitative real-time PCR (qPCR) for rickettsiae and
Orientia tsutsugamushi (scrub typhus). Deoxyribonucleic acid
(DNA) was extracted from serum using QIAamp DNA mini
kits (QIAGEN) following manufacturer’s instruction and
stored at  80 C. The qPCR assays developed to detect Rickett-
sia spp. (Rick17), tick-borne rickettsiae (Trick), Rickettsia
typhi (Rtyph), Rickettsia felis (Rfelis), and O. tsutsugamushi
(Otsu47) were performed as previously described.
19,20 Briefly,
primer pairs were used in separate qPCR assays in a 25 mL
final volume: Rick17, Trick, and Rtyph assays contained 2 mL
of DNA, 12.5 mLo f2+TaqMan Universal PCR Master Mix
(Cat. no. ABI 4304437), 0.4 mM for each primer, and 0.3 mM
of probe. Orientia tsutsugamushi qPCR assay contained 5 mL
FIGURE 2. Catchment area (gray) of febrile surveillance study.
248 KASPER AND OTHERSof DNA, 12.5 mLo f2+TaqMan Universal PCR Master mix
(Cat. no. ABI 4304437), 0.4 mM for each primer and 0.3 mM
of probe; and the R. felis PCR assay contained 2 mLo fD N A ,
12.5 mLo f2 +TaqMan Universal PCR Master mix (Cat.
no. ABI 4304437), 0.4 mM for each primer and 0.4 mMo f
probe. The Applied Biosystems 7500 real time thermocycler
(Applied Biosystems) was used for all real-time PCR assays.
The thermocycling program used consisted of the following
parameters; 50 Cf o r2m i n u t e s ,9 5  C for 10 minutes, and
60cycleswith95 Cfor15seconds,60 Cfor30seconds.
rRT-PCR for hantaviruses. Hantavirus RNA was extracted
from serum using QIAamp viral RNA mini kits (QIAGEN)
following manufacturer’s instruction and stored at  80 C. An
rRT-PCR assay was used to detect Hantaviruses serotypes
Hantaan (HTN), Puumala (PUU), Seoul (SEO), and Dobrava-
Belgrade (DOB).
21 One-step rRT-PCR was performed in
a final volume of 25 mL containing 5 mL of extracted RNA,
12.5 mL of buffer mix, 0.5 mLo fM g S O 4,a n d0 . 6 2 5mL
Superscript III/Platinum Taq-Enzyme mix, 0.5 mLo fR N A s e -
out (Invitrogen), 0.4 mM for each primer, and 0.25 mMo f
probe. The Rotor-Gene 6000 real time thermocyler (Corbett
LifeScience,Sydney,Australia)wasusedforallPCRreactions.
The thermocycling parameters for all targets consisted of 50 C
for 15 minutes, 95 C for 2 minutes, and 45 cycles with 95 Cf o r
15seconds,55 Cfor30seconds,and72 Cfo r1mi nu te .
Nested RT-PCR for detection of hepatitis E viruses. The RNA
was extracted from serum using QIAamp viral RNA mini kits
(QIAGEN) following manufacturer’s instruction and stored
at  80 C. The nonstructural (NS) gene of Hepatitis E virus was
detected using a nested reverse real-time PCR assay.
22 The RT
reactions were performed in 25 mLc o n t a i n i n g5mL of Qiagen
buffer mix (Qiagen, Cat. no. 210212) and 1 mLo fe n z y m em i x ,
1 mL of 10 mM dNTP, 0.63 mM of each primer, 0.15 mLo f4 0U
RNase inhibitor (Promega, Cat. no. N2511), and 5 mLo fR N A
template. The PCR thermal cycling was performed as follows:
45 C for 30 minutes, 94 C for 15 minutes, and 40 cycles with
94 C for 1 minute, 45 C for 1 minute, 72 C for 1 minute, and
then 72 C for 7 minutes. The PCR reactions were performed
using the Applied Biosystems 9700 (Applied Biosystems). An
nPCR reaction was carried out at a total volume of 25 mL.
The reaction contained 2.5 mL of ABI PCR buffer (Applied
Biosystems, Cat. no. N808-0009), 1.5 mM MgCl2,2mLo f
10 mM dNTP, 0.75 mM forward primer and reverse primer,
0.125 mLo f5Uo fA m p l i T a qD N AP o l y m e r a s e ,a n d5mLo f
diluted (1:50) RT-PCR product. The cycle conditions of nPCR
reaction are as follows: 94 C for 2 minutes, and 40 cycles with
94 C for 1 minute, 55 C for 1 minute, 72 C for 1 minute, and
then 72 C for 7 minutes. Products were visualized on 2%
agarose gelsstained with ethidiumbromide underUV light.
Statistical analysis. All data was double-data entered
into MS Access (Microsoft Inc., Redmond, WA). Data was
imported into SAS v 9.1 (SAS, Cary, NC), which was used for
allstatistical analyses.
RESULTS
From December 2006 through December 2009, 9,997
patients were enrolled (Figure 3). All patients enrolled met
the criteria of fever (> 38.0 C). Among the 9,997 patients,
89.3% had a complete questionnaire. A serum sample, nose
and/or throat swab, and blood culture sample was available
from99.8%,99.7%,and 98.2%,respectively.
The median age of enrolled patients was 13 years of age
(interquartile range [IQR] 6–28) years of age (Table 1) and
53.9%weremale.Patients reportedbothrecenttravel toother
provinces or countries (7.9%) and travel into forested areas
(7.1%). Study subject occupation was recorded, however stu-
dents and children accounted for 63.5% of enrolled study sub-
jects. Among study subjects reporting a specific occupation,
grain farmers were most common (31.3%). Contact with cat-
tle (8.3%), chickens (7.7%), and dogs (7.0%) were the most
common reported animal exposures. Prior medication usage
wasreportedby36.6%ofenrolledsubjects.Themostcommon
symptoms reported by enrolled patients included headache
(69.5%), cough (57.5%), sore throat (46.6%), chills (48.1%),
and malaise (46.8%) (Table 1). Among enrolled participants,
65.7% presented with signs and symptoms characteristic of
influenza-like illness, 17.1% with gastroenteritis, and 1.4%
with jaundice. Close contact with an individual who had sim-
ilar symptoms was reported among 9.0% of participants. Of
the enrolled patients, 10.1% were hospitalized or referred for
hospitalization.
Laboratory testing was performed for agents believed to
be endemic to the region in addition to a variety of emerging
pathogens (Table 2). Of enrolled patients, 19.9% (N ¼ 1,983)
were PCR positive for influenza. Dengue virus was considered
the probable cause of illness (as defined by only a positive IgM
result) in 842 enrollees (8.4%) and confirmed (as defined by
a positive PCR result) in 883 cases (8.9%). All four serotypes
of dengue were detected during the study period. Malaria was
identifiedamong7.2%(N¼716)ofpatients,withPlasmodium
falciparum identified in 30.2% of malaria cases. In addition, a
total of 19 mixed infections of Plasmodiuom vivax and P. fal-
ciparum were identified. Acute leptospirosis was serologically
identified in 20.8% of study subjects. Hepatitis A IgM testing
was performed on the first 3,243 patients enrolled, 56 (1.7%)
of the patients were positive. Hepatitis B surface antigen test-
ing was done on the first 4,596 enrollees, and 261 (5.8%) were
positive. Follow-up on testing of HBsAG-positive samples
identified eight samples that were also positive for IgM. A
hepatitis E IgM response was detected among 11.1% of par-
ticipants.ThePCRtestingof517serumsamplesthatwerepos-
itive or equivocal for Hepatitis E IgM identified five samples
positive for hepatitisE nucleic acid.
Serologicaltestingofpairedsampleswasconductedforanti-
bodies against chikungunya, hantavirus, and rickettsiae (scrub
typhusgroup,typhusgroup,andspottedfevergroup)(Table3).
Testing of chikungunya IgG among the first 753 patients
enrolled in 2007 identified a previous exposure in 16.3%.
Chikungunya IgM was identified among 0.1% (2 of 1,438) of
enrolled patients and PCR of patients presenting with fever
andjoint pain identified threecases out of 571samples tested.
Hantavirus IgG was detected in convalescent specimens of
8.1% of patients tested. Paired testing of acute and convales-
cent samples identified 71 patients that had evidence of an
acute hantavirus infection. No IgM-positive or PCR-positive
cases of hantaviral infection were identified by IgM or molec-
ularanalysis.
Testing for scrub typhus group, typhus group, and spotted
fever group rickettsiae-specific IgG in convalescent specimens
identified seroprevalences of 7.0%, 13.4%, and 11.6%, respec-
tively (Table 3). From positive convalescent samples, testing
of paired samples to identify acute cases identified 35, 56, and
21 cases of scrub typhus, typhus, and spotted fever, respectively.
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byqPCRassaysconfirmedtwocasesofscrubtyphusandonecase
of murine typhus. No species of the spotted fever group were
identifiedbyqPCR.
Blood culture testing yielded a bacterial isolate in 6.3% (642
of 9,821) of study subjects (Table 4). The most common iso-
lates were non-pathogenic skin flora (e.g., coagulase-negative
Staphylococcus, micrococcus sp., bacillus sp. (non-anthracis);
however, a number of known pathogens were also identified
including Salmonella typhi (57), Staphylococcus aureus (4),
Burkholderia pseudomallei (2), group C Streptococcus (1), and
Moraxellacatarrhalis (6)(Table 4).
To identify active co-infections, we limited analysis to
patients who were positive by a combination of PCR, blood
culture, and/or malaria microscopy. There were 94 (1.0%)
patients whose specimens were positive by two or more of
these tests (Table 5). Influenza was identified with con-
firmed dengue in 55 cases, with malaria in 8 cases, and an
isolate from blood culture in 10 cases. Dengue was identi-
fied with malaria in 15 cases and a blood culture isolate in
4c a s e s( 1B. pseudomallei/dengue-2, 2 S. typhi/dengue-4,
and 1 S. typhi/dengue-2). In one patient, influenza was iden-
tified with Salmonella cholerasuis and dengue-4.
DISCUSSION
The purpose of this study was to identify the infectious
etiologies of AFI among patients 2 years of age and older
TABLE 1
Demographics of enrolled patients from Dec. 2006 to Dec. 2009
Demographic and clinical information n % Demographic and clinical information n %
Patients enrolled 9,997 Temperature, mean (SD) 39 (0.6)
Age (years), mean (SD) 19.6(16.9) Malaise 4,675 46.8
Age (years), median (SD) 13.0(16.9) Chills 4,807 48.1
Gender Muscle aches 2,319 23.2
Male 5,392 54.0 Rash 197 2.0
Female 4,601 46.0 Lesion 96 1.0
Medication 3,627 36.3 Joint pain 1,894 19.0
Travel history Headache 6,947 69.5
Province/country 793 7.9 Seizure 83 0.8
Jungle 708 7.1 Sore throat 4,655 46.6
Occupation Cough 5,748 57.5
Cattle/sheep farmer 9 0.1 Shortness of breath 964 9.7
Grain farmer 3,133 31.3 Nausea 876 8.8
Poultry farmer 18 0.2 Vomiting 1,332 13.4
Driver 16 0.2 Abdominal cramp 2,412 24.2
Factory worker 387 3.9 Diarrhea 580 5.8
Fisherman 17 0.2 Bloody stool 66 0.7
Office worker 50 0.5 Bloody urine 20 0.2
Other 6,347 63.5 Bleeding 25 0.3
Exposure history Jaundice 132 1.4
Cats 278 2.8
Dogs 700 7.0 Person same symptom 893 9.0
Cattle 824 8.3 Patient disposition
Horses 5 0.1 Admitted at hospital 990 9.9
Goat/sheep 5 0.1 Outpatient follow-up 8,975 89.9
Pigs 81 0.8 Referred to hospital 15 0.2
Monkeys 7 0.1
Rodents 8 0.1
Chickens 765 7.7
Ducks 186 1.9
FIGURE 3. Enrollment by month Dec. 2006–Dec. 2009
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This is the first comprehensive study to identify etiologies of
AFIin thegeneral populationof Cambodia.
Our study enrolled nearly 10,000 patients over a 3-year
period. During this time period, there was a seasonality to
enrollment that corresponded to the rainy season, which
roughly corresponds with the influenza season in Cambodia
23
peakingin August–October ofeach year.
In this study, we identified influenza, Leptospira, dengue,
hepatitis E, and malaria as the most frequently identified
pathogens associated with AFI among Cambodians. Previous
regional studies had identified similar etiologies among
patients with AFI,
5,6 with some variation of etiologies and dis-
tribution that could be based on the sampled population or the
pathogen testing schemes. However, we identified that many
of the acute serological responses to Leptospira and hepatitis
E were associated with co-detection of other organisms (data
not shown).
A large number of study subjects were classified chronic
hepatitis B cases; additional testing revealed that only a small
number of those individuals presented with an AFI caused by
hepatitis B. A recent study of hepatitis B among blood donors
found a similar percentage of HBsAG-positive volunteers
24
in Cambodia.
Despite a lack of jaundice reported among the study popu-
lation, a high percentage of patients showed an acute serologi-
cal response to hepatitis E. Of the 175 patients presenting with
clinical jaundice, only 29 (16.6%) were identified to have a
positive hepatitis E IgM response. This represents a diagnostic
challenge that may be caused by a long-term IgM response or
continuousexposure in theenvironment to hepatitis Evirus.
A large number of patients were positive for an acute sero-
logical responseto Leptospira.A recent study focusing onhos-
pitalized patients in Cambodia found a similar prevalence of
acute or prior Leptospira infection, with approximately half of
thepatientspresentingwithanacuteinfection.
25Althoughlep-
tospirosis has been documented to be endemic in the region,
26
the more definitive microscopic agglutination testing (MAT)
was not performed on these samples. In addition, a recent
study showed poor diagnostic accuracy of the Leptospira IgM
PanBioELISAcomparedwithMATtesting.
27Furtherlabora-
tory studies and analysis is needed to understand the contribu-
tionof Leptospira to AFIin Cambodia.
Almost 1% of enrollees tested had results suggesting an
acute hantavirus infection. However, PCR testing failed
to identify Hantaan, Seoul, Puumala, or Dobrava strains
among any study subjects. This may reflect genetic differ-
ences of Hantavirus strains in Cambodia that need to be fur-
ther defined. Alternatively, the serology results may be from
a cross-reaction from a similar yet previously unidentified
pathogen. Previous studies conducted in Cambodia have iden-
tified the presence of Hantaviruses in rodent populations.
28,29
In addition, because of biosafety and biosecurity limitations,
we were unable to perform antibody neutralization studies on
these samples.
The pathogen yield from blood culture was considerably
low, likely caused by the single sampling used. However,
we were able to detect a number of known pathogens (e.g.,
B. pseudomallei, S. typhi, S. paratyphi) as well as common
skin contaminants (e.g., coagulase negative Staphylococcus,
microbacterium). In addition, there were a number of patho-
gens that have limited reports of causing disease such as
Sphingomonas paucimobilus,
30 that require further investiga-
tion. Planned studies at these sites will expand molecular and
serological techniques to determine the prevalence of bacte-
rial pathogensamong patientswith AFIin Cambodia.
Co-detection was limited to PCR-positive results or culture/
smear results where organisms were visualized. This work
TABLE 2
Distribution of pathogens identified among enrolled patients from
Dec. 2006 to Dec. 2009
Pathogens Tested cases Positive (N) Positive (%)
Influenza viruses 9,968 1,983 19.9
H1N1 224 11.3
H3N2 827 41.7
H5N1 1 < 0.1
Pandemic H1N1 286 14.4
Influenza B 627 31.6
Influenza A, untyped 18 0.9
H1N1 and influenza B 1 < 0.1
H3N2 and influenza B 3 0.2
Pandemic H1N1 and H3N2 4 0.2
Malaria 9,954 716 7.2
P. falciparum 216 30.2
P. vivax 481 67.2
P. falciparum and P. vivax 19 2.6
Dengue 9,975
IgM positive only (probable
dengue)
842
PCR positive (confirmed dengue) 883
Serotype-1 83 9.4
Serotype-2 398 45.1
Serotype-3 108 12.2
Serotype-4 294 33.3
Blood-borne pathogen 9,821 629 6.3
Leptospirosis IgM 9,975 2,076 20.8
Hepatitis A IgM 3,243 58 1.7
Hepatitis B sAG 4,596 267 5.8
Hepatitis B IgM 267 8 3.0
Hepatitis E IgM 9,353 1038 11.1
Hepatitis E PCR 517 5 1.0
TABLE 3
Pathogens identified from testing of acute and convalescent serum
samples
Pathogens Tested cases Positive (N) Positive (%)
Chikungunya IgG (convalescent) 753 123 16.3
Chikungunya IgM 1438 2 0. 1
Chikungunya PCR 571 3 0.5
Hantavirus IgG (convalescent) 5675 459 8.1
Hantavirus 4 +IgG rise and/or
seroconverter
459 71 15.5
Hantavirus PCR 79 0 0.0
Scrub typhus group IgG
(convalescent)
1906 133 7.0
Scrub typhus group-specific
IgG 4-fold rise in titer or
seroconversion
133 35 26.3
Orientia tsutsugamushi-specific
qPCR
67 2 3.0
Typhus group IgG (convalescent) 1946 261 13.4
Typhus group-specific IgG 4-fold
rise in titer or seroconversion
261 56 21.5
R. typhi-specific qPCR 83 1 1.2
Spotted fever group IgG
(convalescent)
1263 146 11.6
Spotted fever group-specific
IgG 4-fold rise in titer or
seroconversion
146 21 14.4
Tick-borne rickettsiae-specific
qPCR
37 0 0.0
FEBRILE SURVEILLANCE IN CAMBODIA 251identified a number of unique co-infections such as Dengue
and B. pseudomallei and S. typhi. The co-infections with
malaria may represent asymptomatic infections among our
study population. Currently, our group has several malaria-
specific studies underway, accessing prevalence, incidence,
and drug resistance. Our study identified over 50 co-infected
casesofinfluenza anddengue,previous reportshavealsoiden-
tifiedcasesandconcurrentoutbreaks.
5,31,32Furtherstudiesare
required to better understand the clinical outcome of patients
who havetestedpositive for multiplepathogens.
The use of laboratory-based syndromic surveillance can
alert regional officials and describe common infectious etiolo-
gies circulating in the region during a specific time period.
Furthermore, laboratory-based syndromic surveillance can
be used to help define symptoms and information that can be
used for electronic-based surveillance programs and help to
guide outbreakresponse andlaboratory testing.
Testing for a number of pathogens in all samples as opposed
to using a staged screening strategy allowed us to identify
co-infections that may have otherwise been missed. The diver-
sity of etiological agents, an inability to identify an etiology in
themajorityofenrolledpatients,andtheprevalenceofmultiple
infections, demonstrate the complexity of diagnosis and treat-
mentofmedicalcareprovidersinthisregionofCambodia.
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TABLE 4
Organisms isolated from 9821 patient blood cultures
Organism TOTAL Organism TOTAL
Pathogens: Achromobacter xylosoxidans 1 Potential pathogens: Acinetobacter baumannii/calcoaceticus 3
Actinomyces radingae 3 Acinetobacter lwoffii 3
Beta hemolytic streptococci group C 1 Bacillus sp. 2
Brevundimonas vesicularis 7 Chryseobacterium indologenes 1
Burkholderia cepacia 1 Mannheimia haemolytica/P. trehalosi 3
Burkholderia pseudomallei 2 Ochrobactrum anthropi 1
Edwardsiella tarda 1 Pseudomonas fluorescens 1
Escherichia coli 12 Pseudomonas oryzihabitans 1
Group D Salmonella sp. non-typhi 1 Pseudomonas putida 1
Gemella morbillorum 2 Pseudomonas stutzeri 1
Moraxella catarrhalis 6
Moraxella sp. non-catarrhalis 3 Likely contaminants:
Neisseria sp. non-meningitidis 2 Aerococcus viridans 1
Pasteurella sp. 1 Arthrobacter sp. 37
Pseudomonas aeruginosa 1 Brevibacterium sp. 1
Ralstonia pickettii 1 Cellulomonas sp. 1
Rhodococcus sp. 15 Cellulosimicrobium cellulans 1
Salmonella choleraesuis 10 Coagulase negative Staphylococcus 203
Salmonella Group D sp. non-typhi 1 Corynebacterium sp. 16
Salmonella ser. Paratyphi A 6 Leifsonia aquatica 1
Salmonella typhi 57 Microbacterium sp. 35
Sphingomonas paucimobilis 6 Micrococcus sp. 20
Staphylococcus aureus 4
Stenotrophomonas maltophilia 2
Streptococcus constellatus 1
Streptococcus mitis 1
Streptococcus pneumonia 1
Aspergillus sp. 2
Candida sp. other than albicans 14
TABLE 5
List of unique or uncommon co-infections identified from polymerase
chain reaction (PCR) positive
Co-infection (n) n Notes
Influenza/dengue 55 55 are PCR positive for dengue
Influenza/malaria 8
Influenza/blood culture 10
Dengue/malaria 15 15 are PCR positive for dengue
Dengue/blood culture 1 B. pseudomallei and dengue-2
Dengue/blood culture 2 S. typhi and dengue-4
Dengue/blood culture 1 S. typhi and dengue-2
Malaria/blood culture 1
Influenza/dengue/blood culture 1 S. cholerasuis and dengue-4
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